Uncategorized
Join us at POCT – The Power to Disrupt, 23rd August, London
We invite you to visit us at the POCT – The Power to Disrupt event, at The Royal College of Pathologists, London on the 23rd of August 2023. POCT – The Power to Disrupt is the 2nd event this year organised by POCT Innovators in London, following on from the success of the previous event…
Read MoreMeet us at Primary Care and Public Health Conference, 17-18th May, Birmingham
We invite you to visit us at the Primary Care and Public Health Conference, at NEC Birmingham, on the 17th and 18th May 2023. Primary Care and Public Health is the UK’s leading event for GPs, trainee GPs, managers, podiatrists, physiotherapists, nurses, midwives, dietitians and other NHS and private clinicians working in primary and community…
Read MoreJoin us at Diabetes UK Conference, 26 – 28 April, Liverpool
We invite you to visit Una Health at the Diabetes UK Professional Conference, on the 26th – 28th April, at the Exhibition Centre in Liverpool. The DUKPC 2023 will be a fully face-to-face event to be held at the Exhibition Centre Liverpool. Designed by healthcare professionals and spanning disciplines from primary to specialist care, podiatry, paediatrics and dietetics,…
Read MoreJoin us at the ‘Integrated Care Systems 2023’ Conference, 23rd March, London
We invite you to visit Una Health at the Integrated Care Systems 2023 Conference, taking place at the Royal Society of Medicine, London, on 23rd March 2023. Integrated Care Systems 2023 – The Future of Population Health Systems will allow NHS organisations, local councils and others to come together and discuss collective responsibility for managing resources,…
Read MoreQuikRead go® CRP outperforms other CRP point-of-care tests in an analytical performance study
A recent study published in PLOS ONE journal compared the analytical performance of 17 C-reactive protein (CRP) point of care (POC) tests. The purpose of the study was to enable more decentralised use of CRP testing at the point of care, which can support healthcare providers in the clinical management of patients. The study involved…
Read MoreIntroducing a new generation of pregnancy blood tests
Una Health will be distributing a new generation of rapid pregnancy blood tests from NG Biotech. NG Biotech introduces a new standard of hCG rapid blood tests, with results in as little as 5 minutes. With a sensitivity of 10mlU/ml and facilitating high throughput, these tests are saving on average 85 minutes in Emergency Rooms[1].…
Read MoreIntroducing our product of the quarter, Sight OLO®
We are delighted to announce that Sight OLO® from Sight Diagnostics® is our product of the quarter. OLO is the first lab-grade Full Blood Count (FBC) analyser truly designed for point of care. Combining digital microscopy with artificial intelligence, OLO can deliver FBC results in minutes, providing the full breadth and accuracy of lab testing. Moreover, OLO is the first…
Read MoreKey takeaways from the oncology world
Una Health recently exhibited at the Oncology Professional Care 2022, 24th-25th of May. It was a great occasion to network and socialise with new and familiar faces across the oncology world. Being the first oncology expo for Una Health, we had the perfect opportunity to make some introductions and also gain a more in-depth understanding of…
Read MoreUna Health stay up-to-date: take home messages from ECCMID 2022
Written by: Carolyne Horner Date: 03.05.22 At the end of April 2022, Carolyne Horner represented Una Health by attending the 32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), held online and in-person, in Lisbon Portugal. The meeting comprised four days of educational workshops, meet-the-expert sessions, presentations, industry symposia, not to mention two exhibition…
Read MoreSiemens Atellica® VTLi Analyser is our innovative product of the quarter
Siemens Healthineers Atellica® VTLi Patient-Side Analyser is our product of the quarter, which Una Health will be distributing into primary care in the UK. The symptoms of myocardial infarction (MI), also known as a heart attack, can be varied and atypical so the use of testing for biomarker cardiac troponin I is crucial to transform…
Read More